ADAM9: Difference between revisions
m Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}) |
m Bot: HTTP→HTTPS |
||
Line 1: | Line 1: | ||
{{Infobox_gene}} | |||
{{ | '''Disintegrin and metalloproteinase domain-containing protein 9''' is an [[enzyme]] that in humans is encoded by the ''ADAM9'' [[gene]].<ref name="pmid8647900">{{cite journal | vauthors = Weskamp G, Kratzschmar J, Reid MS, Blobel CP | title = MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains | journal = J Cell Biol | volume = 132 | issue = 4 | pages = 717–26 |date=Jul 1996| pmid = 8647900 | pmc = 2199860 | doi =10.1083/jcb.132.4.717 }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma)| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=8754| accessdate = }}</ref> | ||
| | |||
| | |||
| | |||
| | |||
| | |||
}} | |||
== Function == | |||
This gene encodes a member of the ADAM ([[a disintegrin and metalloprotease]] domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom [[disintegrin]]s, and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. The protein encoded by this gene interacts with [[SH3 domain]]-containing proteins, binds mitotic arrest deficient 2 beta protein, and is also involved in TPA-induced [[ectodomain]] shedding of membrane-anchored heparin-binding EGF-like growth factor. Two alternative splice variants have been identified, encoding distinct isoforms.<ref name="entrez"/> | |||
==References== | == Interactions == | ||
{{reflist | |||
==Further reading== | ADAM9 has been shown to [[Protein-protein interaction|interact]] with: | ||
* [[MAD2L2]],<ref name = pmid10527948>{{cite journal | date = Nov 1999 | vauthors = Nelson KK, Schlöndorff J, Blobel CP | title = Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta | journal = Biochem. J. | volume = 343 | issue = Pt 3| pages = 673–80 | pmid = 10527948 | pmc = 1220601 | doi = 10.1042/0264-6021:3430673}}</ref> | |||
* [[SH3GL2]],<ref name = pmid10531379/> and | |||
* [[SNX9]]<ref name = pmid10531379>{{cite journal | date = Oct 1999 | vauthors = Howard L, Nelson KK, Maciewicz RA, Blobel CP | title = Interaction of the metalloprotease disintegrins MDC9 and MDC15 with two SH3 domain-containing proteins, endophilin I and SH3PX1 | journal = J. Biol. Chem. | volume = 274 | issue = 44 | pages = 31693–9 | pmid = 10531379 | doi = 10.1074/jbc.274.44.31693}}</ref> | |||
== References == | |||
{{reflist}} | |||
== Further reading == | |||
{{refbegin | 2}} | {{refbegin | 2}} | ||
* {{cite journal | vauthors = Mazzocca A, Coppari R, De Franco R, Cho JY, Libermann TA, Pinzani M, Toker A | title = A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions | journal = Cancer Res. | volume = 65 | issue = 11 | pages = 4728–38 |date=June 2005| pmid = 15930291 | doi = 10.1158/0008-5472.CAN-04-4449 | url = | issn = }} | |||
*{{cite journal | vauthors=Nomura N, Miyajima N, Sazuka T |title=Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1. |journal=DNA Res. |volume=1 |issue= 1 |pages= 27–35 |year= 1995 |pmid= 7584026 |doi=10.1093/dnares/1.1.27 |display-authors=etal}} | |||
*{{cite journal | *{{cite journal | vauthors=Nomura N, Miyajima N, Sazuka T |title=Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1 (supplement). |journal=DNA Res. |volume=1 |issue= 1 |pages= 47–56 |year= 1995 |pmid= 7584028 |doi=10.1093/dnares/1.1.47 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=McKie N, Dallas DJ, Edwards T |title=Cloning of a novel membrane-linked metalloproteinase from human myeloma cells. |journal=Biochem. J. |volume=318 |issue= 2|pages= 459–62 |year= 1996 |pmid= 8809033 |doi= | pmc=1217643 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=McKie N, Edwards T, Dallas DJ |title=Expression of members of a novel membrane linked metalloproteinase family (ADAM) in human articular chondrocytes. |journal=Biochem. Biophys. Res. Commun. |volume=230 |issue= 2 |pages= 335–9 |year= 1997 |pmid= 9016778 |doi= 10.1006/bbrc.1996.5957 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Izumi Y, Hirata M, Hasuwa H |title=A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. |journal=EMBO J. |volume=17 |issue= 24 |pages= 7260–72 |year= 1999 |pmid= 9857183 |doi= 10.1093/emboj/17.24.7260 | pmc=1171072 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Roghani M, Becherer JD, Moss ML |title=Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity. |journal=J. Biol. Chem. |volume=274 |issue= 6 |pages= 3531–40 |year= 1999 |pmid= 9920899 |doi=10.1074/jbc.274.6.3531 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Nelson KK, Schlöndorff J, Blobel CP |title=Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta. |journal=Biochem. J. |volume=343 |issue= 3|pages= 673–80 |year= 2000 |pmid= 10527948 |doi= 10.1042/0264-6021:3430673| pmc=1220601 }} | ||
*{{cite journal | | *{{cite journal | vauthors=Howard L, Nelson KK, Maciewicz RA, Blobel CP |title=Interaction of the metalloprotease disintegrins MDC9 and MDC15 with two SH3 domain-containing proteins, endophilin I and SH3PX1. |journal=J. Biol. Chem. |volume=274 |issue= 44 |pages= 31693–9 |year= 1999 |pmid= 10531379 |doi=10.1074/jbc.274.44.31693 }} | ||
*{{cite journal | | *{{cite journal | vauthors=Zhou M, Graham R, Russell G, Croucher PI |title=MDC-9 (ADAM-9/Meltrin gamma) functions as an adhesion molecule by binding the alpha(v)beta(5) integrin. |journal=Biochem. Biophys. Res. Commun. |volume=280 |issue= 2 |pages= 574–80 |year= 2001 |pmid= 11162558 |doi= 10.1006/bbrc.2000.4155 }} | ||
*{{cite journal | | *{{cite journal | vauthors=Namba K, Nishio M, Mori K |title=Involvement of ADAM9 in multinucleated giant cell formation of blood monocytes. |journal=Cell. Immunol. |volume=213 |issue= 2 |pages= 104–13 |year= 2002 |pmid= 11831872 |doi= 10.1006/cimm.2001.1873 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Eto K, Huet C, Tarui T |title=Functional classification of ADAMs based on a conserved motif for binding to integrin alpha 9beta 1: implications for sperm-egg binding and other cell interactions. |journal=J. Biol. Chem. |volume=277 |issue= 20 |pages= 17804–10 |year= 2002 |pmid= 11882657 |doi= 10.1074/jbc.M200086200 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Lim JM, Lee JH, Wee WR, Joo CK |title=Downregulated expression of ADAM9 in anterior polar cataracts. |journal=Journal of cataract and refractive surgery |volume=28 |issue= 4 |pages= 697–702 |year= 2002 |pmid= 11955914 |doi=10.1016/S0886-3350(01)01236-6 }} | ||
*{{cite journal | | *{{cite journal | vauthors=Hotoda N, Koike H, Sasagawa N, Ishiura S |title=A secreted form of human ADAM9 has an alpha-secretase activity for APP. |journal=Biochem. Biophys. Res. Commun. |volume=293 |issue= 2 |pages= 800–5 |year= 2002 |pmid= 12054541 |doi= 10.1016/S0006-291X(02)00302-9 }} | ||
*{{cite journal | | *{{cite journal | vauthors=Amour A, Knight CG, English WR |title=The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs. |journal=FEBS Lett. |volume=524 |issue= 1–3 |pages= 154–8 |year= 2002 |pmid= 12135759 |doi=10.1016/S0014-5793(02)03047-8 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Strausberg RL, Feingold EA, Grouse LH |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 | pmc=139241 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Mohan S, Thompson GR, Amaar YG |title=ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts |journal=Biochemistry |volume=41 |issue= 51 |pages= 15394–403 |year= 2003 |pmid= 12484779 |doi=10.1021/bi026458q |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Asai M, Hattori C, Szabó B |title=Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase |journal=Biochem. Biophys. Res. Commun. |volume=301 |issue= 1 |pages= 231–5 |year= 2003 |pmid= 12535668 |doi=10.1016/S0006-291X(02)02999-6 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=O'Shea C, McKie N, Buggy Y |title=Expression of ADAM-9 mRNA and protein in human breast cancer |journal=Int. J. Cancer |volume=105 |issue= 6 |pages= 754–61 |year= 2003 |pmid= 12767059 |doi= 10.1002/ijc.11161 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Grützmann R, Lüttges J, Sipos B |title=ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma |journal=Br. J. Cancer |volume=90 |issue= 5 |pages= 1053–8 |year= 2004 |pmid= 14997207 |doi= 10.1038/sj.bjc.6601645 | pmc=2409625 |display-authors=etal}} | ||
*{{cite journal | | |||
*{{cite journal | | |||
}} | |||
{{refend}} | {{refend}} | ||
{{ | ==External links== | ||
{{ | * [http://AtlasGeneticsOncology.org/Genes/ADAM9ID573ch8p11.html ADAM9] on the [[Atlas of Genetics and Cytogenetics in Oncology and Haematology|Atlas of Genetics and Oncology]] | ||
* {{UCSC gene info|ADAM9}} | |||
{{Metalloproteinases}} | |||
[[Category:Peptidase]] | |||
[[Category:EC 3.4.24]] | |||
{{gene-8-stub}} |
Latest revision as of 17:48, 29 August 2017
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
Disintegrin and metalloproteinase domain-containing protein 9 is an enzyme that in humans is encoded by the ADAM9 gene.[1][2]
Function
This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. The protein encoded by this gene interacts with SH3 domain-containing proteins, binds mitotic arrest deficient 2 beta protein, and is also involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. Two alternative splice variants have been identified, encoding distinct isoforms.[2]
Interactions
ADAM9 has been shown to interact with:
References
- ↑ Weskamp G, Kratzschmar J, Reid MS, Blobel CP (Jul 1996). "MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains". J Cell Biol. 132 (4): 717–26. doi:10.1083/jcb.132.4.717. PMC 2199860. PMID 8647900.
- ↑ 2.0 2.1 "Entrez Gene: ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma)".
- ↑ Nelson KK, Schlöndorff J, Blobel CP (Nov 1999). "Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta". Biochem. J. 343 (Pt 3): 673–80. doi:10.1042/0264-6021:3430673. PMC 1220601. PMID 10527948.
- ↑ 4.0 4.1 Howard L, Nelson KK, Maciewicz RA, Blobel CP (Oct 1999). "Interaction of the metalloprotease disintegrins MDC9 and MDC15 with two SH3 domain-containing proteins, endophilin I and SH3PX1". J. Biol. Chem. 274 (44): 31693–9. doi:10.1074/jbc.274.44.31693. PMID 10531379.
Further reading
- Mazzocca A, Coppari R, De Franco R, Cho JY, Libermann TA, Pinzani M, Toker A (June 2005). "A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions". Cancer Res. 65 (11): 4728–38. doi:10.1158/0008-5472.CAN-04-4449. PMID 15930291.
- Nomura N, Miyajima N, Sazuka T, et al. (1995). "Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1". DNA Res. 1 (1): 27–35. doi:10.1093/dnares/1.1.27. PMID 7584026.
- Nomura N, Miyajima N, Sazuka T, et al. (1995). "Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1 (supplement)". DNA Res. 1 (1): 47–56. doi:10.1093/dnares/1.1.47. PMID 7584028.
- McKie N, Dallas DJ, Edwards T, et al. (1996). "Cloning of a novel membrane-linked metalloproteinase from human myeloma cells". Biochem. J. 318 (2): 459–62. PMC 1217643. PMID 8809033.
- McKie N, Edwards T, Dallas DJ, et al. (1997). "Expression of members of a novel membrane linked metalloproteinase family (ADAM) in human articular chondrocytes". Biochem. Biophys. Res. Commun. 230 (2): 335–9. doi:10.1006/bbrc.1996.5957. PMID 9016778.
- Izumi Y, Hirata M, Hasuwa H, et al. (1999). "A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor". EMBO J. 17 (24): 7260–72. doi:10.1093/emboj/17.24.7260. PMC 1171072. PMID 9857183.
- Roghani M, Becherer JD, Moss ML, et al. (1999). "Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity". J. Biol. Chem. 274 (6): 3531–40. doi:10.1074/jbc.274.6.3531. PMID 9920899.
- Nelson KK, Schlöndorff J, Blobel CP (2000). "Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta". Biochem. J. 343 (3): 673–80. doi:10.1042/0264-6021:3430673. PMC 1220601. PMID 10527948.
- Howard L, Nelson KK, Maciewicz RA, Blobel CP (1999). "Interaction of the metalloprotease disintegrins MDC9 and MDC15 with two SH3 domain-containing proteins, endophilin I and SH3PX1". J. Biol. Chem. 274 (44): 31693–9. doi:10.1074/jbc.274.44.31693. PMID 10531379.
- Zhou M, Graham R, Russell G, Croucher PI (2001). "MDC-9 (ADAM-9/Meltrin gamma) functions as an adhesion molecule by binding the alpha(v)beta(5) integrin". Biochem. Biophys. Res. Commun. 280 (2): 574–80. doi:10.1006/bbrc.2000.4155. PMID 11162558.
- Namba K, Nishio M, Mori K, et al. (2002). "Involvement of ADAM9 in multinucleated giant cell formation of blood monocytes". Cell. Immunol. 213 (2): 104–13. doi:10.1006/cimm.2001.1873. PMID 11831872.
- Eto K, Huet C, Tarui T, et al. (2002). "Functional classification of ADAMs based on a conserved motif for binding to integrin alpha 9beta 1: implications for sperm-egg binding and other cell interactions". J. Biol. Chem. 277 (20): 17804–10. doi:10.1074/jbc.M200086200. PMID 11882657.
- Lim JM, Lee JH, Wee WR, Joo CK (2002). "Downregulated expression of ADAM9 in anterior polar cataracts". Journal of cataract and refractive surgery. 28 (4): 697–702. doi:10.1016/S0886-3350(01)01236-6. PMID 11955914.
- Hotoda N, Koike H, Sasagawa N, Ishiura S (2002). "A secreted form of human ADAM9 has an alpha-secretase activity for APP". Biochem. Biophys. Res. Commun. 293 (2): 800–5. doi:10.1016/S0006-291X(02)00302-9. PMID 12054541.
- Amour A, Knight CG, English WR, et al. (2002). "The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs". FEBS Lett. 524 (1–3): 154–8. doi:10.1016/S0014-5793(02)03047-8. PMID 12135759.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Mohan S, Thompson GR, Amaar YG, et al. (2003). "ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts". Biochemistry. 41 (51): 15394–403. doi:10.1021/bi026458q. PMID 12484779.
- Asai M, Hattori C, Szabó B, et al. (2003). "Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase". Biochem. Biophys. Res. Commun. 301 (1): 231–5. doi:10.1016/S0006-291X(02)02999-6. PMID 12535668.
- O'Shea C, McKie N, Buggy Y, et al. (2003). "Expression of ADAM-9 mRNA and protein in human breast cancer". Int. J. Cancer. 105 (6): 754–61. doi:10.1002/ijc.11161. PMID 12767059.
- Grützmann R, Lüttges J, Sipos B, et al. (2004). "ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma". Br. J. Cancer. 90 (5): 1053–8. doi:10.1038/sj.bjc.6601645. PMC 2409625. PMID 14997207.
External links
- ADAM9 on the Atlas of Genetics and Oncology
- Human ADAM9 genome location and ADAM9 gene details page in the UCSC Genome Browser.
This article on a gene on human chromosome 8 is a stub. You can help Wikipedia by expanding it. |